Cited by 126Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology

Open access

Liu, R., Zhou, X.‐W., Tanila, H., Bjorkdahl, C., Wang, J.‐Z., Guan, Z.‐Z., Cao, Y., Gustafsson, J.‐Å., Winblad, B., Pei, J.‐J.·2008·Journal of Cellular and Molecular Medicine

DOI 10.1111/j.1582-4934.2008.00249.xPMC PMC3823485

Open this paper in CoChat — free account

Abstract

Down-regulation of protein phosphatase 2A (PP2A) is thought to play a critical role in tau hyperphosphorylation in Alzheimer's disease (AD). In vitro phosphorylation of PP2A catalytic subunit at Y307 efficiently inactivates PP2A. A specific antibody against phosphorylated (p) PP2A (Y307) (PP2Ac-Yp307) was used to investigate possible PP2A down-regulation by known pathophysiological changes associated with AD, such as Abeta accumulation and oestrogen deficiency. Immunohistochemistry and immunofluorescence confocal microscopy showed an aberrant accumulation of PP2Ac-Yp307 in neurons that bear pretangles or tangles in the susceptible brain regions, such as the entorhinal cortical cortex and the hippocampus. Experimentally, increased PP2Ac-Yp307 was observed in mouse N2a neuroblastoma cells that stably express the human amyloid precursor protein with Swedish mutation (APPswe) compared with wild-type, and in the brains of transgenic APPswe/ presenilin (PS1, A246E) mice, which corresponded to the increased tau phosphorylation. Treating N2a cells with Abeta25-35 mimicked the changes of PP2Ac-Yp307 and tau phosphorylation in N2a APPswe cells. Knockout of oestrogen receptor (ER) alpha or ERbeta gave similar changes of PP2Ac-Yp307 level and tau phosphorylation in the mouse brain. Taken together, these findings suggest that increased PP2A phosphorylation (Y307) can be mediated by Abeta deposition or oestrogen deficiency in the AD brain, and consequently compromise dephosphorylation of abnormally hyperphosphorylated tau, and lead to neurofibrillary tangle formation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1111/j.1582-4934.2008.00249.x

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

RETRACTED: Aβ(1–42)-induced JNK and ERK activation in rabbit hippocampus is differentially regulated by lithium but is not involved in the phosphorylation of tau
Ghribi, O., Pramoonjago, P., Herman, M. M., Spaulding, N. K., & Savory, J. (2003) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.09.001 · Cited by 33
Retracted
Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling
Janssens, V., & Goris, J. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3530417 · Cited by 1,927
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
Lewis, J., Dickson, D. W., Lin, W.-L., Chisholm, L., Corral, A., Jones, G., Yen, S.-H., Sahara, N., Skipper, L., Yager, D., et al. (2001) · Science · doi:10.1126/science.1058189 · Cited by 1,611
Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils
Götz, J., Chen, F., van Dorpe, J., & Nitsch, R. M. (2001) · Science · doi:10.1126/science.1062097 · Cited by 1,526
Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo
Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80230-5 · Cited by 1,478
Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling
Janssens, V., & Goris, J. (2001) · Biochemical Journal · doi:10.1042/bj3530417 · Cited by 1,392
Aβ Immunotherapy Leads to Clearance of Early, but Not Late, Hyperphosphorylated Tau Aggregates via the Proteasome
Oddo, S., Billings, L., Kesslak, J. P., Cribbs, D. H., & LaFerla, F. M. (2004) · Neuron · doi:10.1016/j.neuron.2004.07.003 · Cited by 780
Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation
Chen, J., Martin, B. L., & Brautigan, D. L. (1992) · Science · doi:10.1126/science.1325671 · Cited by 601
Phosphoprotein Phosphatase Activities in Alzheimer Disease Brain
Gong, C., Singh, T. J., Grundke‐Iqbal, I., & Iqbal, K. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03603.x · Cited by 527
Block of Long-Term Potentiation by Naturally Secreted and Synthetic Amyloid β-Peptide in Hippocampal Slices Is Mediated via Activation of the Kinases c-Jun N-Terminal Kinase, Cyclin-Dependent Kinase 5, and p38 Mitogen-Activated Protein Kinase as well as Metabotropic Glutamate Receptor Type 5
Wang, Q., Walsh, D. M., Rowan, M. J., Selkoe, D. J., & Anwyl, R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1633-03.2004 · Cited by 437

Show all 41 references

Sorted by citations

Post-translational modifications of tau protein: Implications for Alzheimer's disease
Martin, L., Latypova, X., & Terro, F. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2010.12.023 · Cited by 683
Abnormal Hyperphosphorylation of Tau: Sites, Regulation, and Molecular Mechanism of Neurofibrillary Degeneration
Wang, J., Xia, Y., Grundke, I., & Iqbal, K. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129031 · Cited by 547
Self-citation
Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease
Liu, F., Shi, J., Tanimukai, H., Gu, J., Gu, J., Grundke-Iqbal, I., Iqbal, K., & Gong, C.-X. (2009) · Brain · doi:10.1093/brain/awp099 · Cited by 439
The Role of Tau in Alzheimer's Disease and Related Disorders
Medeiros, R., Baglietto‐Vargas, D., & LaFerla, F. M. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00177.x · Cited by 484
Curcumin-primed exosomes potently ameliorate cognitive function in AD mice by inhibiting hyperphosphorylation of the Tau protein through the AKT/GSK-3β pathway
Wang, H., Sui, H., Zheng, Y., Jiang, Y., Shi, Y., Liang, J., & Zhao, L. (2019) · Nanoscale · doi:10.1039/c9nr01255a · Cited by 324
All roads lead to PP 2A: exploiting the therapeutic potential of this phosphatase
Sangodkar, J., Farrington, C. C., McClinch, K., Galsky, M. D., Kastrinsky, D. B., & Narla, G. (2016) · The FEBS Journal · doi:10.1111/febs.13573 · Cited by 312
Protein phosphatase 2A dysfunction in Alzheimerâ€™s disease
Sontag, J.-M., & Sontag, E. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00016 · Cited by 304
Possible Implications of Insulin Resistance and Glucose Metabolism in Alzheimer's Disease Pathogenesis
Bosco, D., Fava, A., Plastino, M., Montalcini, T., & Pujia, A. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01318.x · Cited by 283
Tau protein phosphatases in Alzheimer's disease: The leading role of PP2A
Martin, L., Latypova, X., Wilson, C. M., Magnaudeix, A., Perrin, M.-L., & Terro, F. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2012.06.008 · Cited by 265
Protein Serine/Threonine Phosphatases: Keys to Unlocking Regulators and Substrates
Brautigan, D. L., & Shenolikar, S. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-012332 · Cited by 191
mTOR‐dependent signalling in Alzheimer's disease
Pei, J., & Hugon, J. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00509.x · Cited by 190
Self-citation
Uncovering Molecular Biomarkers That Correlate Cognitive Decline with the Changes of Hippocampus' Gene Expression Profiles in Alzheimer's Disease
Ravetti, M. G., Rosso, O. A., Berretta, R. E., & Moscato, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010153 · Cited by 144
The role of intracellular zinc release in aging, oxidative stress, and Alzheimer’s disease
McCord, M. C., & Aizenman, E. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00077 · Cited by 142
Mammalian Target of Rapamycin (mTor) Mediates Tau Protein Dyshomeostasis
Tang, Z., Bereczki, E., Zhang, H., Wang, S., Li, C., Ji, X., Branca, R. M., Lehtiö, J., Guan, Z., Filipčík, P., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.435123 · Cited by 124
Self-citation
Zinc induces protein phosphatase 2A inactivation and tau hyperphosphorylation through Src dependent PP2A (tyrosine 307) phosphorylation
Xiong, Y., Jing, X.-P., Zhou, X.-W., Wang, X.-L., Yang, Y., Sun, X.-Y., Qiu, M., Cao, F.-Y., Lu, Y.-M., Liu, R., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.07.003 · Cited by 122
Self-citation
Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A
Salas, A., Ponnusamy, S., Senkal, C. E., Meyers‐Needham, M., Selvam, S. P., Saddoughi, S. A., Apohan, E., Sentelle, R. D., Smith, C. D., Gault, C. R., et al. (2011) · Blood · doi:10.1182/blood-2010-08-300772 · Cited by 122
Fibroblast growth factor 21 ameliorates neurodegeneration in rat and cellular models of Alzheimer’s disease
Chen, S., Chen, S., Sun, Y., Xu, Z., Wang, Y., Yao, S., Yao, W., & Gao, X. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101133 · Cited by 120
Mechanism of inhibition of PP2A activity and abnormal hyperphosphorylation of tau by I2PP2A/SET
Arnaud, L. T., Chen, S., Liu, F., Li, B., Khatoon, S., Grundke, I., & Iqbal, K. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.07.020 · Cited by 109
Protein Phosphatases and Alzheimer's Disease
Braithwaite, S. P., Stock, J. B., Lombroso, P. J., & Nairn, A. C. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-396456-4.00012-2 · Cited by 111
Protein phosphatase 2A as a therapeutic target in inflammation and neurodegeneration
Clark, A. R., & Ohlmeyer, M. H. J. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.05.016 · Cited by 108
Icariin attenuates β-amyloid-induced neurotoxicity by inhibition of tau protein hyperphosphorylation in PC12 cells
Zeng, K., Ko, H., Yang, H. O., & Wang, X. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.07.020 · Cited by 106
Untangling Tau and Iron: Exploring the Interaction Between Iron and Tau in Neurodegeneration
Rao, S. S., & Adlard, P. A. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00276 · Cited by 108
Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A
Zhou, X.-W., Gustafsson, J.-Α., Tanila, H., Björkdahl, C., Liu, R., Winblad, B. G., & Pei, J.-J. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.05.013 · Cited by 104
Self-citation
Homocysteine, Vitamin B12, and Folic Acid Levels in Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Elderly: Baseline Characteristics in Subjects of the Australian Imaging Biomarker Lifestyle Study
Faux, N. G., Ellis, K. A., Porter, L., Fowler, C. J., Laws, S. M., Martins, R. N., Pertile, K. K., Rembach, A., Rowe, C. C., Rumble, R. L., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110752 · Cited by 97
Tau hyperphosphorylation induces oligomeric insulin accumulation and insulin resistance in neurons
Rodriguez‐Rodriguez, P., Matton, A., Merino‐Serrais, P., Parrado‐Fernández, C., Rábano, A., Winblad, B. G., Ávila, J., Ferrer, I., & Cedazo-Mínguez, Á. (2017) · Brain · doi:10.1093/brain/awx256 · Cited by 99
Self-citation
Tau pathology involves protein phosphatase 2A in Parkinsonism-dementia of Guam
Arif, M., Kazim, S. F., Grundke, I., Garruto, R. M., & Iqbal, K. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322614111 · Cited by 92
CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits in Alzheimer’s Disease
Shentu, Y.-P., Huo, Y., Feng, X.-L., Gilbert, J., Zhang, Q., Liuyang, Z.-Y., Wang, X.-L., Wang, G., Zhou, H., Wang, X.-C., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.009 · Cited by 90
“We have reported that Y307 phosphorylation of PP2A was increased in AD and contributed to PP2A inhibition (Liu et al., 2008).”
Self-citation
Microcystin-LR induces cytoskeleton system reorganization through hyperphosphorylation of tau and HSP27 via PP2A inhibition and subsequent activation of the p38 MAPK signaling pathway in neuroendocrine (PC12) cells
Meng, G., Sun, Y., Fu, W., Guo, Z., & Xu, L. (2011) · Toxicology · doi:10.1016/j.tox.2011.09.085 · Cited by 84
Animal models reveal role for tau phosphorylation in human disease
Götz, J., Gladbach, A., Pennanen, L., van Eersel, J., Schild, A., David, D. C., & Ittner, L. M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.09.008 · Cited by 82
Microtubule-associated protein tau as a therapeutic target in Alzheimer's disease
Iqbal, K., Gong, C., & Liu, F. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.870156 · Cited by 76
Stem cells-derived exosomes alleviate neurodegeneration and Alzheimer’s pathogenesis by ameliorating neuroinflamation, and regulating the associated molecular pathways
Khan, M. I., Jeong, E. S., Khan, M. Z., Shin, J. H., & Kim, J. D. (2023) · Scientific Reports · doi:10.1038/s41598-023-42485-4 · Cited by 77
p70 S6 Kinase and Tau in Alzheimer's Disease
Pei, J.-J., Björkdahl, C., Zhang, H., Zhou, X., & Winblad, B. G. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14405 · Cited by 75
Self-citation
Advances in the Pathogenesis of Alzheimer’s Disease: Focusing on Tau-Mediated Neurodegeneration
Duan, Y., Dong, S., Gu, F., Hu, Y., & Zhao, Z. (2012) · Translational Neurodegeneration · doi:10.1186/2047-9158-1-24 · Cited by 80
Crocin-protected malathion-induced spatial memory deficits by inhibiting TAU protein hyperphosphorylation and antiapoptotic effects
Mohammadzadeh, L., Abnous, K., Razavi, B. M., & Hosseinzadeh, H. (2019) · Nutritional Neuroscience · doi:10.1080/1028415x.2018.1492772 · Cited by 67
Tau phosphorylation and neuronal apoptosis induced by the blockade of PP2A preferentially involve GSK3β
Martin, L., Page, G., & Terro, F. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.05.010 · Cited by 68
Inhibition of glycogen synthase kinase-3β downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A
Martin, L., Magnaudeix, A., Esclaire, F., Yardin, C., & Terro, F. (2008) · Brain Research · doi:10.1016/j.brainres.2008.11.057 · Cited by 62
The Beta-Amyloid Protein of Alzheimer’s Disease: Communication Breakdown by Modifying the Neuronal Cytoskeleton
Mokhtar, S., Bakhuraysah, M. M., Cram, D. S., & Petratos, S. (2013) · International Journal of Alzheimer s Disease · doi:10.1155/2013/910502 · Cited by 60
Se‐Methylselenocysteine Ameliorates Neuropathology and Cognitive Deficits by Attenuating Oxidative Stress and Metal Dyshomeostasis in Alzheimer Model Mice
Xie, Y., Liu, Q., Zheng, L. P., Wang, B., Qu, X., Ni, J., Zhang, Y., & Du, X. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800107 · Cited by 58
Cytoplasmic zinc promotes IL-1β production by monocytes and macrophages through mTORC1-induced glycolysis in rheumatoid arthritis
Kim, B., Kim, H. Y., Yoon, B. R., Yeo, J., Jung, J. I., Yu, K., Kim, H. C., Yoo, S., Park, J. K., Kang, S. W., et al. (2022) · Science Signaling · doi:10.1126/scisignal.abi7400 · Cited by 57
Folate/vitamin-B12 Prevents Chronic Hyperhomocysteinemia-Induced Tau Hyperphosphorylation and Memory Deficits in Aged Rats
Wei, W., Liu, Y., Zhang, C.-E., Wang, Q., Wei, Z., Mousseau, D. D., Wang, J., Tian, Q., & Liu, G. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110770 · Cited by 55
Self-citation
Direct Activation of Protein Phosphatase 2A (PP2A) by Tricyclic Sulfonamides Ameliorates Alzheimer's Disease Pathogenesis in Cell and Animal Models
Wei, H., Zhang, H., Wang, X., Xie, J., An, D., Wan, L., Wang, J., Zeng, Y., Shu, X., Westermarck, J. K., et al. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00841-6 · Cited by 54
Self-citation
Tolfenamic acid inhibits GSK-3β and PP2A mediated tau hyperphosphorylation in Alzheimer’s disease models
Zhang, H., Wang, X., Xu, P., Ji, X., Chi, T., Liu, P., & Zou, L. (2020) · The Journal of Physiological Sciences · doi:10.1186/s12576-020-00757-y · Cited by 54
Tau kinases and phosphatases
Ávila, J. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00214.x · Cited by 57
Insulin resistance and bioenergetic manifestations: Targets and approaches in Alzheimer's disease
Sharma, V., & Singh, T. G. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118401 · Cited by 52
Environmental factors in the development and progression of late-onset Alzheimer’s disease
Wainaina, M. N., Chen, Z., & Zhong, C. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1425-9 · Cited by 53
Protein phosphatase 2A in Alzheimer's disease
Liu, R., & Wang, J. (2009) · Pathophysiology · doi:10.1016/j.pathophys.2009.02.008 · Cited by 51
Self-citation
Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets
Pei, J.-J., Sjögren, M., & Winblad, B. (2008) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328314b78b · Cited by 49
Self-citation
Prolyl oligopeptidase inhibition activates autophagy via protein phosphatase 2A
Svarcbahs, R., Jäntti, M. H., Kilpeläinen, T. P., Julku, U. H., Urvas, L., Kivioja, S., Norrbacka, S., & Myöhänen, T. T. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104558 · Cited by 50
Glycogen synthase kinase-3β regulates Tyr307 phosphorylation of protein phosphatase-2A via protein tyrosine phosphatase 1B but not Src
Yao, X., Zhang, X., Yin, Y., Liu, B., Luo, D., Liu, D., Chen, N., Ni, Z.-F., Wang, X., Wang, Q., et al. (2011) · Biochemical Journal · doi:10.1042/bj20110347 · Cited by 47
Self-citation
Sustained postexercise increases in AS160 Thr642and Ser588phosphorylation in skeletal muscle without sustained increases in kinase phosphorylation
Schweitzer, G. G., Arias, E. B., & Cartee, G. D. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00619.2012 · Cited by 47
Expression of Alzheimer-like pathological human tau induces a behavioral motor and olfactory learning deficit in Drosophila melanogaster
Beharry, C., Alaniz, M. E., & Alonso, A. D. C. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130617 · Cited by 39
Protein Phosphatase 2A: a Double-Faced Phosphatase of Cellular System and Its Role in Neurodegenerative Disorders
Nematullah, M., Hoda, M. N., & Khan, F. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0444-3 · Cited by 44
Chronic hyperglycemia induced via the heterozygous knockout of Pdx1 worsens neuropathological lesion in an Alzheimer mouse model
Guo, C., Zhang, S., Li, J., Ding, C., Yang, Z., Chai, R., Wang, X., & Wang, Z. (2016) · Scientific Reports · doi:10.1038/srep29396 · Cited by 42
Microcystin-lr induces protein phosphatase 2a alteration in a human liver cell line
Sun, Y., Zheng, Q., Sun, Y.-T., Huang, P., Guo, Z., & Xu, L. (2013) · Environmental Toxicology · doi:10.1002/tox.21854 · Cited by 40
Unveiling Clusters of RNA Transcript Pairs Associated with Markers of Alzheimer’s Disease Progression
Arefin, A. S., Mathieson, L., Johnstone, D. M., Berretta, R. E., & Moscato, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045535 · Cited by 39
Exogenous brain-derived neurotrophic factor attenuates cognitive impairment induced by okadaic acid in a rat model of Alzheimer's disease
Xu, A., Yang, Y., Sun, Y., & Zhang, C. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.241471 · Cited by 39
Zinc binds to and directly inhibits protein phosphatase 2A in vitro
Xiong, Y., Luo, D., Wang, X., Qiu, M., Yang, Y., Yan, X., Wang, J., Ye, Q., & Liu, R. (2015) · Neuroscience Bulletin · doi:10.1007/s12264-014-1519-z · Cited by 38
Self-citation
Basis for MAP4 Dephosphorylation-related Microtubule Network Densification in Pressure Overload Cardiac Hypertrophy
Cheng, G., Takahashi, M., Shunmugavel, A., Wallenborn, J. G., DePaoli-Roach, A. A., Gergs, U., Neumann, J., Kuppuswamy, D., Menick, D. R., & Cooper, G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.148650 · Cited by 42
Glycogen synthase kinase‐3β regulates leucine‐309 demethylation of protein phosphatase‐2A via PPMT1 and PME‐1
Yao, X., Li, X., Zhang, X., Yin, Y., Liu, B., Luo, D., Wang, Q., Wang, J., & Liu, G. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.06.018 · Cited by 37
Self-citation
mTor Is a Signaling Hub in Cell Survival: A Mass-Spectrometry-Based Proteomics Investigation
Tang, Z., Baykal, A. T., Gao, H., Quezada, H. C., Zhang, H., Bereczki, E., Serhatlı, M., Baykal, B., Acıoğlu, Ç., Wang, S., et al. (2014) · Journal of Proteome Research · doi:10.1021/pr500192g · Cited by 37
Self-citation
Nmnat2 Attenuates Tau Phosphorylation Through Activation of PP2A
Cheng, X., Zhao, K.-P., Jiang, X., Du, L., Li, X., Ma, Z., Yao, J., Luo, Y., Duan, D.-X., Wang, J., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122173 · Cited by 38
Self-citation
A prolyl oligopeptidase inhibitor reduces tau pathology in cellular models and in mice with tauopathy
Eteläinen, T. S., Silva, M. C., Uhari-Väänänen, J. K., Lorenzo, F. D., Jäntti, M. H., Cui, H., Chavero‐Pieres, M., Kilpeläinen, T. P., Mechtler, C., Svarcbahs, R., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abq2915 · Cited by 36
PTPA variants and impaired PP2A activity in early-onset parkinsonism with intellectual disability
Fevga, C., Tesson, C., Mascaro, A. C., Courtin, T., van Coller, R., Sakka, S., Ferraro, F., Farhat, N., Bardien, S., Damak, M., et al. (2022) · Brain · doi:10.1093/brain/awac326 · Cited by 34
Morroniside-Induced PP2A Activation Antagonizes Tau Hyperphosphorylation in a Cellular Model of Neurodegeneration
Yang, C., Kuai, X.-X., Gao, W., Yu, J., Wang, Q., Li, L., & Zhang, L. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150728 · Cited by 35
Interactions Between Glycogen Synthase Kinase 3β, Protein Kinase B, and Protein Phosphatase 2A in Tau Phosphorylation in Mouse N2a Neuroblastoma Cells
Zhou, X., Winblad, B. G., Guan, Z., & Pei, J.-J. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1113 · Cited by 33
Self-citation
Partial Inhibition of Mitochondrial Complex I Reduces Tau Pathology and Improves Energy Homeostasis and Synaptic Function in 3xTg-AD Mice
Stojakovic, A., Chang, S.-Y., Nesbitt, J. J., Pichurin, N. P., Ostroot, M., Aikawa, T., Kanekiyo, T., & Trushina, E. V. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-201015 · Cited by 31
Implication of JNK pathway on tau pathology and cognitive decline in a senescence-accelerated mouse model
Orejana, L., Barros-Miñones, L., Aguirre, N., & Puerta, E. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.03.001 · Cited by 32
Liposomes functionalized with acidic lipids rescue Aβ-induced toxicity in murine neuroblastoma cells
Bereczki, E., Re, F., Masserini, M., Winblad, B. G., & Pei, J. J. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.05.009 · Cited by 32
Self-citation
The Role of Insulin and Insulin-Like Growth Factor-1/FoxO-Mediated Transcription for the Pathogenesis of Obesity-Associated Dementia
Moll, L., & Schubert, M. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/384094 · Cited by 31
Early glycogen synthase kinase‐3β and protein phosphatase 2A independent tau dephosphorylation during global brain ischaemia and reperfusion following cardiac arrest and the role of the adenosine monophosphate kinase pathway
Majd, S., Power, J. H. T., Koblar, S. A., & Grantham, H. J. M. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13277 · Cited by 31
Morin exerts protective effects on encephalopathy and sepsis-associated cognitive functions in a murine sepsis model
Xie, X., Li, M.-Z., Yao, E., Gong, S., Xie, J., Gao, W., Xie, Z., Li, Z., Bai, X., Liu, L., et al. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.03.019 · Cited by 32
Therapeutic Re-Activation of Protein Phosphatase 2A in Acute Myeloid Leukemia
Ramaswamy, K., Spitzer, B. G., & Kentsis, A. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00016 · Cited by 30
Diphenyl ditelluride induces hypophosphorylation of intermediate filaments through modulation of DARPP-32-dependent pathways in cerebral cortex of young rats
Heimfarth, L., Loureiro, S. O., Reis, K. P., de Lima, B. O., Zamboni, F., Lacerda, S., Soska, Â. K., Wild, L., da Rocha, J. B. T., & Pessoa‐Pureur, R. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0746-6 · Cited by 26
Pleiotropy of PP2A Phosphatases in Cancer with a Focus on Glioblastoma IDH Wildtype
Kashani, E., & Vassella, E. (2022) · Cancers · doi:10.3390/cancers14215227 · Cited by 22
Cytoplasmic SET induces tau hyperphosphorylation through a decrease of methylated phosphatase 2A
Chasseigneaux, S., Clamagirand, C., Huguet, L., Gorisse-Hussonnois, L., Rose, C., & Allinquant, B. (2014) · BMC Neuroscience · doi:10.1186/1471-2202-15-82 · Cited by 22
Neuroprotective Effects of Green Tea Seed Isolated Saponin Due to the Amelioration of Tauopathy and Alleviation of Neuroinflammation: A Therapeutic Approach to Alzheimer’s Disease
Khan, M. I., Khan, M. Z., Shin, J. H., Shin, T. S., Lee, Y. B., Kim, M. Y., & Kim, J. D. (2022) · Molecules · doi:10.3390/molecules27072079 · Cited by 24
Neurosteroid metabolites of testosterone and progesterone differentially inhibit ERK phosphorylation induced by amyloid β in SH-SY5Y cells and primary cortical neurons
Mendell, A. L., Chung, B. Y. T., Creighton, C. E., Kalisch, B. E., Bailey, C. D. C., & MacLusky, N. J. (2018) · Brain Research · doi:10.1016/j.brainres.2018.02.023 · Cited by 24
Folate is related to phosphorylated neurofilament‐H and P‐tau (Ser396) in rat brain
Obeid, R., Schlundt, J. C., Umanskaya, N., Herrmann, W., & Herrmann, M. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07280.x · Cited by 21
Phosphorylation on the PPP2R5D B regulatory subunit modulates the biochemical properties of protein phosphatase 2A
Yu, U.-Y., & Ahn, J. (2010) · BMB Reports · doi:10.5483/bmbrep.2010.43.4.263 · Cited by 21
Abnormal phosphorylation of tau protein and neuroinflammation induced by laparotomy in an animal model of postoperative delirium
Yu, L., Wen, G., Zhu, S., Hu, X., Huang, C., & Yang, Y. (2021) · Experimental Brain Research · doi:10.1007/s00221-020-06007-2 · Cited by 20
Lack of JWA Enhances Neurogenesis and Long-Term Potentiation in Hippocampal Dentate Gyrus Leading to Spatial Cognitive Potentiation
Sha, S., Xu, J., Lu, Z., Hong, J., Qu, W., Zhou, J., & Chen, L. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-9010-4 · Cited by 20
The testosterone metabolite 3α-androstanediol inhibits oxidative stress-induced ERK phosphorylation and neurotoxicity in SH-SY5Y cells through an MKP3/DUSP6-dependent mechanism
Mendell, A. L., & MacLusky, N. J. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.12.012 · Cited by 23
Blockade of AMPA Receptor Regulates Mitochondrial Dynamics by Modulating ERK1/2 and PP1/PP2A-Mediated DRP1-S616 Phosphorylations in the Normal Rat Hippocampus
Kim, J.-E., Choi, H., Song, H., & Kang, T. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00179 · Cited by 21
Signaling Mechanisms and Disrupted Cytoskeleton in the Diphenyl Ditelluride Neurotoxicity
Pessoa‐Pureur, R., Heimfarth, L., & da Rocha, J. B. T. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/458601 · Cited by 18
Inhibition of PP2A enhances the osteogenic differentiation of human aortic valvular interstitial cells via ERK and p38 MAPK pathways
Xie, F., Li, F., Li, R., Liu, Z., Shi, J., Zhang, C., & Dong, N. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118086 · Cited by 19
Microcystin-Leucine-Arginine Induces Tau Pathology Through Bα Degradation via Protein Phosphatase 2A Demethylation and Associated Glycogen Synthase Kinase-3β Phosphorylation
Zhang, Y., Zhang, J., Wang, E., Qian, W., Fan, Y., Feng, Y., Yin, H., Li, Y., Wang, Y., & Yuan, T. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx271 · Cited by 19
SET SUMOylation promotes its cytoplasmic retention and induces tau pathology and cognitive impairments
Qin, M., Li, H., Bao, J., Xia, Y., Ke, D., Wang, Q., Liu, R., Wang, J., Zhang, B., Shu, X., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0663-0 · Cited by 19
Self-citation
Loss of Lysosomal Proteins Progranulin and Prosaposin Associated with Increased Neurofibrillary Tangle Development in Alzheimer Disease
Mendsaikhan, A., Tooyama, I., Serrano, G. E., Beach, T. G., & Walker, D. G. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab056 · Cited by 17
Designing composite cryogel carriers for tyrosine adsorption
Öztürk, G., Saylan, Y., & Deni̇zli̇, A. (2020) · Separation and Purification Technology · doi:10.1016/j.seppur.2020.117622 · Cited by 18
Silencing of the PP2A catalytic subunit causes HER-2/neu positive breast cancer cells to undergo apoptosis
Wong, L. L., Zhang, D., Chang, C. F., & Koay, E. S. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.06.007 · Cited by 17
Circumventing embryonic lethality with Lcmt1 deficiency: generation of hypomorphic Lcmt1 mice with reduced protein phosphatase 2A methyltransferase expression and defects in insulin signaling
MacKay, K. B., Tu, Y., Young, S. G., & Clarke, S. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065967 · Cited by 14
Could protein phosphatase 2A and glycogen synthase kinase-3 beta be targeted by natural compounds to ameliorate Alzheimer’s pathologies?
Manoharan, S. D., Hamid, H. A., Hashim, N. F. M., Cheema, M. S., Chiroma, S. M., Mustapha, M., & Mehat, M. Z. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148793 · Cited by 14
Arsenic Induces GSK3β-Dependent p-Tau, Neuronal Apoptosis, and Cognitive Impairment via an Interdependent Hippocampal ERα and IL-1/IL-1R1 Mechanism in Female Rats
Gupta, K., Vishwakarma, J., Garg, A., Pandey, R., Jain, V., Gupta, R., Das, U., Roy, S. K., & Bandyopadhyay, S. (2022) · Toxicological Sciences · doi:10.1093/toxsci/kfac087 · Cited by 14
Asp664 cleavage of amyloid precursor protein induces tau phosphorylation by decreasing protein phosphatase 2A activity
Park, S. S., Jung, H., Kim, Y., Park, T. K., Kim, C., Choi, H., Mook‐Jung, I. H., Koo, E. H., & Park, S. A. (2012) · Journal of Neurochemistry · doi:10.1111/jnc.12032 · Cited by 14
High fructose induces dysfunctional vasodilatation via PP2A-mediated eNOS Ser1177 dephosphorylation
Jin, J., Liu, J., Luo, Y. M., He, H., Zheng, X., Zheng, C., Huang, Y., & Chen, Y. (2022) · Nutrition & Metabolism · doi:10.1186/s12986-022-00659-3 · Cited by 12
SCR-1693 inhibits tau phosphorylation and improves insulin resistance associated cognitive deficits
Bi, A., An, W., Wang, C., Hua, Y. F., Fang, F., Dong, X., Chen, R., Zhang, Z., & Luo, L. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108027 · Cited by 12
Hyperhomocysteinemia selectively alters expression and stoichiometry of intermediate filament and induces glutamate‐ and calcium‐mediated mechanisms in rat brain during development
Loureiro, S. O., Heimfarth, L., Pelaez, P. D. L., Lacerda, B. A., Vidal, L. F., Soska, Â. K., dos Santos, N. G., Andrade, C. M. B., Tagliari, B., Scherer, E. B. S., et al. (2009) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2009.10.002 · Cited by 11
Progesterone regulates the phosphorylation of protein phosphatases in the brain
Amorim, M. A. R., Guerra‐Araiza, C., Pernía, O., Silva, E. F. D. C. E., & García‐Segura, L. M. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22442 · Cited by 11
PKCα Isoform Inhibits Insulin Signaling and Aggravates Neuronal Insulin Resistance
Mishra, D., Reddy, I., & Dey, C. S. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03486-6 · Cited by 10
Protein Phosphatase 2A Deficiency in Macrophages Increases Foam Cell Formation and Accelerates Atherosclerotic Lesion Development
Li, R. Q., Zhang, C., Xie, F., Zhou, X., Hu, X., Shi, J., Du, X., Lin, Z., & Dong, N. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.745009 · Cited by 10
Self-citation

Authors: Liu, R., Zhou, X. ‐., Tanila, H., Bjorkdahl, C., Wang, J. ‐., Guan, Z. ‐., Cao, Y., Gustafsson, J. ‐., Winblad, B., & Pei, J. ‐.
Affiliations: Karolinska Institutet (SE)
University of Eastern Finland (FI)
Huazhong University of Science and Technology (CN)
Guiyang Medical University (CN)
Corresponding author: Liu, R.
ORCID: Liu, R.
Zhou, X.‐W.
Tanila, H.
Guan, Z.‐Z.
Winblad, B.
Venue: Journal of Cellular and Molecular Medicine
Publisher: Wiley
Published: 2008-01
Volume: 12
Issue: 1
Pages: 241-257
ISSN: 1582-1838 (ISSN-L)
1582-4934
DOI: 10.1111/j.1582-4934.2008.00249.x
PMC: PMC3823485
OpenAlex: W1995042713
Cited by: 125
References: 41
Citations by year: 2026: 1 · 2024: 2 · 2023: 5 · 2022: 8 · 2021: 5 · 2020: 8 · 2019: 8 · 2018: 8 · 2017: 4 · 2016: 3 · 2015: 3 · 2014: 11 · 2013: 10 · 2012: 12
FWCI: 8.35
Type: journal article
Language: en
Open access: green
europepmc.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 18 d)
Locations: Journal of Cellular and Molecular Medicine (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: protein phosphatase 2A, Alzheimer's disease, neurofibrillary tangles, tau hyperphosphorylation, amyloid-beta, estrogen deficiency, estrogen receptor alpha, estrogen receptor beta, APPswe, presenilin 1, entorhinal cortex, hippocampus, N2a cells
MeSH terms: Aged, Aged, 80 and over, Alzheimer Disease, Animals, Antibodies, Monoclonal, Estrogens, Female, Humans, Male, Mice, Transgenic, Mutation, Neuroblastoma, Neurons, Phosphorylation, Transfection, Tyrosine, Amyloid beta-Protein Precursor, Neurofibrillary Tangles, tau Proteins, Microscopy, Confocal, Fluorescent Antibody Technique, Indirect, Estrogen Receptor alpha, Estrogen Receptor beta, Mice, Protein Phosphatase 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks